Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anzueto A et al. – It is important to highlight that the control group in the UPLIFT trial consisted of patients with usual treatment for COPD, which included inhaled corticosteroids and/or long–acting beta–2 agonists in up to 62% of cases at baseline and up to 73% of cases at any time during follow–up. The new clinical trials have demonstrated a significant reduction in exacerbations and hospitalisations, even in patients treated with other drugs that can potentially prevent exacerbations.

 

Today in COPD...keeping you current

Short-term change in self-reported COPD symptoms after smoking cessation in an Internet sample
European Respiratory Journal , 12/04/09

Bronchiolar Progenitor Cells
Proceedings of the American Thoracic Society, 12/04/09

Specialized Enteral Formulas in Acute and Chronic Pulmonary Disease
Nutrition in Clinical Practice, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address